Rate of chronicity and time of disappearance of HBsAg following acute hepatitis B

Hepato-Gastroenterology

Volumn 56, Issue 90, 2009, Pages 466-469

  Kuruuzum, Ziya ^a,c   Ozgenç, Onur ^b   Havuk, Ayla ^b   Coşkuner, Ayten ^b   An, Alpay ^b   Çelenkoǧlu, Nida ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b SSK Izmir Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ALCOHOLISM; ARTICLE; CHRONICITY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; VIRUS CARRIER;

ADULT; ALCOHOLISM; CARRIER STATE; CHI-SQUARE DISTRIBUTION; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; MALE; RISK FACTORS;

EID: 67649229309     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lai CL, Ratziu V, Yuen MF, Poynard T: Viral hepatitis B. Lancet 2003; 362:2089-2094.
2. Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control meaures. J Viral Hep 2004; 11:97-107.
3. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003; 39(Suppl 1):S3-S25.
4. Lok AS, Heathcote J, Hoofnagle JH: Management of hepatitis B: 2000-summary of a workshop. Gastroenterolo-gy 2001; 120(7): 1828-1853.
5. Nielsen JO, Dietrichson O, Elling P, Christoffersen P: Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Engl J Med 1971; 285:1157-1160.
6. Redeker AG: Viral hepatitis: clinical aspects. Am J Med Sci 1975; 270:9-16.
7. Wiedmann KH, Brattig NW, Diao GD, Schomerus H, Ddlle W, Berg PA: Serum inhibitory factors (SIF) are of prognostic value in acute viral hepatitis. Lancet 1985; 1:309-312.
8. Seeff LB, Beebe GW, Hoofnagle JH, et al: A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med 1987; 316:965-970.
9. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH: Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987; 92:1844-1850
10. Bortolotti F, Bertaggia A, Crivellaro C, et al: Chronic evolution of acute hepatitis type B: prevalence and predictive markers. Infection 1986; 14:64-67.
11. Roumeliotou-Karayannis A, Tassopoulos N, Richardson SC, Kalafatas P, Papaevangelou G: How often does chronic liver disease follow acute hepatitis B in adults? Infection 1985; 13:174-176.
12. Beasly RP, Hwang LY, Lin CC, Ko YC, Twu SJ: Incidence of hepatitis among students at a university in Taiwan. Am J Epidemiol 1983; 117:213-222.
13. Mayerat C, Mantegani A, Frei PC: Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hep 1999; 6:299-304.
14. Bozdayi AM, Asian N, Bozdayi G, et al: Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients. Arch Virol 2004; 149:2115-2129.
15. Kondo Y, Tsukada K, Takeuchi T, et al: High carrier rate after hepatitis B infection in the elderly. Hepatology 1993; 18:768-774.
16. Hyams KC: Risks of chronicity following acute hepatitis B infection: A review. Clin Infect Dis 1995; 20:992-1000.
17. McMahon BJ, Alward WLM, Hall DB, et al: Acute hepatitis B infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151:599-603.
18. Norkrans G: Clinical, epidemiological and prognostic aspects of hepatitis A, B and non-A, non-B. Scand J Infect Dis 1978; 17(Suppl):l-44.